BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 7509656)

  • 1. Identification of Philadelphia-negative granulocyte-macrophage colony-forming units generated by stroma-adherent cells from chronic myelogenous leukemia patients.
    Carlo-Stella C; Mangoni L; Piovani G; Garau D; Almici C; Rizzoli V
    Blood; 1994 Mar; 83(5):1373-80. PubMed ID: 7509656
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biological and chemical selection of Ph-negative clones.
    Carlo-Stella C; Mangoni L; Piovani G; Garau D; Almici C; Rizzoli V
    Stem Cells; 1993 Oct; 11 Suppl 3():77-82. PubMed ID: 8298479
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fractionation of chronic myelogenous leukemia marrow cells by stroma adherence: implications for marrow purging.
    Rizzoli V; Mangoni L; Piovani G; Garau D; Caramatti C; Almici C; Carlo-Stella C
    Leuk Lymphoma; 1993; 11 Suppl 1():109-12. PubMed ID: 8251884
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BCR/ABL-negative progenitors are enriched in the adherent fraction of CD34+ cells circulating in the blood of chronic phase chronic myeloid leukemia patients.
    Grand FH; Marley SB; Chase A; Titley I; Healy L; Spencer A; Reiter A; Goldman JM; Gordon MY
    Leukemia; 1997 Sep; 11(9):1486-92. PubMed ID: 9305602
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selection of myeloid progenitors lacking BCR/ABL mRNA in chronic myelogenous leukemia patients after in vitro treatment with the tyrosine kinase inhibitor genistein.
    Carlo-Stella C; Dotti G; Mangoni L; Regazzi E; Garau D; Bonati A; Almici C; Sammarelli G; Savoldo B; Rizzo MT; Rizzoli V
    Blood; 1996 Oct; 88(8):3091-100. PubMed ID: 8874208
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of BCR/ABL-negative primitive hematopoietic progenitor cells within chronic myeloid leukemia marrow.
    Leemhuis T; Leibowitz D; Cox G; Silver R; Srour EF; Tricot G; Hoffman R
    Blood; 1993 Feb; 81(3):801-7. PubMed ID: 7679000
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Absence of bcr/abl gene in single hemopoietic progenitors in some patients with chronic myelogenous leukemia.
    Misawa M; Maeda H; Hara H; Yamamoto Y; Furuyama J
    Stem Cells; 1993 Nov; 11(6):536-42. PubMed ID: 7509222
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blast colony-forming cell binding from CML bone marrow, or blood, on stromal layers pretreated with G-CSF or SCF.
    Gidáli J; László E; Halm G; Fehér I
    Cell Prolif; 2002 Feb; 35(1):1-7. PubMed ID: 11856174
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Persistence of malignant hematopoietic progenitors in chronic myelogenous leukemia patients in complete cytogenetic remission following imatinib mesylate treatment.
    Bhatia R; Holtz M; Niu N; Gray R; Snyder DS; Sawyers CL; Arber DA; Slovak ML; Forman SJ
    Blood; 2003 Jun; 101(12):4701-7. PubMed ID: 12576334
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reverse transcription polymerase chain reaction is a reliable assay for detecting leukemic colonies generated by chronic myelogenous leukemia cells.
    Savoldo B; Sammarelli G; Dotti G; Garau D; Regazzi E; Cilloni D; Tabilio A; Rizzoli V; Carlo-Stella C
    Leukemia; 1998 Mar; 12(3):434-40. PubMed ID: 9529140
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stem cell factor as a single agent induces selective proliferation of the Philadelphia chromosome positive fraction of chronic myeloid leukemia CD34(+) cells.
    Moore S; Haylock DN; Lévesque JP; McDiarmid LA; Samels LM; To LB; Simmons PJ; Hughes TP
    Blood; 1998 Oct; 92(7):2461-70. PubMed ID: 9746786
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Abnormal function of the bone marrow microenvironment in chronic myelogenous leukemia: role of malignant stromal macrophages.
    Bhatia R; McGlave PB; Dewald GW; Blazar BR; Verfaillie CM
    Blood; 1995 Jun; 85(12):3636-45. PubMed ID: 7780147
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A quantitative assay that evaluates the capacity of human stromal cells to support granulomonopoiesis in situ.
    Tamayo E; Charbord P; Li J; Hervé P
    Stem Cells; 1994 May; 12(3):304-15. PubMed ID: 7521240
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Growth of erythroid colonies in chronic myelogenous leukemia is independent of erythropoietin only in the presence of steel factor.
    Issaad C; Vainchenker W
    Blood; 1994 Nov; 84(10):3447-56. PubMed ID: 7524739
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selection of benign primitive hematopoietic progenitors in chronic myelogenous leukemia on the basis of HLA-DR antigen expression.
    Verfaillie CM; Miller WJ; Boylan K; McGlave PB
    Blood; 1992 Feb; 79(4):1003-10. PubMed ID: 1371077
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of bcr-abl oligodeoxynucleotides on the clonogenic growth of chronic myelogenous leukaemia cells.
    de Fabritiis P; Skorski T; De Propris MS; Paggi MG; Nieborowska-Skorska M; Lisci A; Buffolino S; Campbell K; Geiser T; Calabretta B
    Leukemia; 1997 Jun; 11(6):811-9. PubMed ID: 9177433
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Morphological and functional characteristics of short-term and long-term bone marrow cultures in chronic myelogenous leukemia.
    Budak-Alpdoğan T; Alpdoğan O; Akoğlu T
    Am J Hematol; 1999 Dec; 62(4):212-20. PubMed ID: 10589076
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preferential sequestration in vitro of BCR/ABL negative hematopoietic progenitor cells among cytokine nonresponsive CML marrow CD34+ cells.
    Veena P; Cornetta K; Davidson A; Agüero B; McMahel J; Traycoff CM; Srour EF
    Bone Marrow Transplant; 1997 Jun; 19(12):1213-21. PubMed ID: 9208115
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypersensitivity of bcr-abl-positive progenitors to hyperthermia in patients with chronic myeloid leukemia.
    Thijsen SF; van Oostveen JW; Schuurhuis GJ; Theijsmeijer AP; Oudejans CB; van Wijk IJ; Langenhuijsen MM; Ossenkoppele GJ
    Leukemia; 1997 Oct; 11(10):1762-8. PubMed ID: 9324298
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Benign marrow progenitors are enriched in the CD34+/HLA-DRlo population but not in the CD34+/CD38lo population in chronic myeloid leukemia: an analysis using interphase fluorescence in situ hybridization.
    Kirk JA; Reems JA; Roecklein BA; Van Devanter DR; Bryant EM; Radich J; Edmands S; Lee A; Torok-Storb B
    Blood; 1995 Jul; 86(2):737-43. PubMed ID: 7541674
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.